Opinion Paper: Why Should Governments Invest in Antibiotic Drug Discovery Against Multi-Drug-Resistant Bacteria?

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|9|2|150-150

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.9, Iss.2, 2014-08, pp. : 150-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Antimicrobial Agents Against Multi-drug-resistant Gram-positive Bacteria: An Overview

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 3, 2012-10 ,pp. : 182-188

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Antimicrobial Agents Against Multi-drug-resistant Gram-negative Bacteria: An Overview

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 3, 2012-10 ,pp. : 175-181

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: War Against Multi-drug-Resistant Pathogens: What is New in the Armory?]

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 3, 2012-10 ,pp. : 173-174

Bentham Science Publishers

Access to resources Recommend Favorite

Multi-Drug Resistant Pulmonary Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 53-57

Bentham Science Publishers

Access to resources Recommend Favorite

Antibiotic Treatment of Multidrug-Resistant Organisms in Cystic Fibrosis

By Conway S.P.  

American Journal of Respiratory Medicine, Vol. 2, Iss. 4, 2003-01 ,pp. : 321-332

Adis International

Access to resources Recommend Favorite